Page last updated: 2024-09-03

hoe 694 and Hyperlipoproteinemia Type II

hoe 694 has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assmann, G; Kehrel, B; Nofer, JR; Seedorf, U; Tepel, M; Walter, M; Wierwille, S; Zidek, W1

Other Studies

1 other study(ies) available for hoe 694 and Hyperlipoproteinemia Type II

ArticleYear
Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
    Circulation, 1997, Mar-18, Volume: 95, Issue:6

    Topics: Adult; Antigens, CD; Binding Sites; Blood Platelets; Guanidines; Humans; Hydrogen-Ion Concentration; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Oxidation-Reduction; P-Selectin; Phosphatidylinositols; Platelet Aggregation; Platelet Membrane Glycoproteins; Propionates; Prostaglandins; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Tetraspanin 30; Thrombin; Type C Phospholipases

1997